Soumen Chakraborty, Ph.D.
Scientist
Institute of Life Sciences
Nalco Square
Bhubaneswar-751023, India
Office:
0091 674 2300137/ 2301476 ext. 207
Fax: 0091 674 2300728
Phone No-
0674-2302420
Email: soumen@ils.res.in, soumen_ils@yahoo.co.in |
|
1.
Chakraborty S., Nair G.B., and Shinoda S.
Pathogenic Vibrios in the natural aquatic
environment. Rev. Environ. Health 1997 Apr-Jun;
12(2): 63-80. Review
2. Hoshino K., Yamasaki
S., Mukhopadhyay A.K., Chakraborty S.,
Basu A., Bhattacharya S.K., Nair G.B., Shimada
T., Takeda Y. Development and evaluation of a
multiplex PCR assay for rapid detection of
toxigenic Vibrio cholerae O1 and O139. FEMS
Immunol. Med. Microbiol. 1998 Mar; 20(3):
201-207
3. Bhattacharya M.K.,
Dutta D., Deb A., Garg P., Chakraborty S.,
Mukhopadhyay A.K., Bhattacharya S.K. Acute
secretory traveler’s diarrhoea caused by Vibrio
cholerae which does not belong to the O1 or O139
serogroup. Nat. Med. J. India, 1998 11 (5),
248.
4. Guhathakurta B.,
Sasmal D., Pal S., Chakraborty S., Nair
G.B., Datta, A. Comparative analysis of
cytotoxin, hemolysin, hemagglutinin and
exocellular enzymes among clinical and
environmental isolates of Vibrio cholerae O139
and non-O1 and, non-O139. FEMS Microbiol Lett.
1999 Oct 15; 179 (2): 401-407
5. Chakraborty S.,
Khanam J., Takeda Y., Nair G.B. Application of
PCR for detection of toxigenic Vibrio cholerae
O1 in water samples during on outbreak of
cholera. Trans. R. Soc. Trop. Med. Hyg. 1999
Sep-Oct; 93 (5): 527-528
6. Basu I., Mukhopadhyay
A.K., Garg P., Chakraborty S., Ramamurthy
T., Yamasaki S., Takeda Y., Nair G.B. Diversity
in the arrangement of the CTX prophages in
classical strains of Vibrio cholerae O1. FEMS
Microbiol Lett. 2000 Jan 1; 182 (1): 35-40
7. Basu A., Garg P.,
Datta S., Chakraborty S., Bhattacharya
T., Khan A., Ramamurthy T., Bhattacharya S.K.,
Yamasaki S., Takeda Y., Nair G.B. Vibrio
cholerae O139 in Calcutta, 1992-1998: incidence,
antibiograms, and genotypes. Emerg. Infect. Dis.
2000 Mar-Apr; 6(2): 139-147
8. Ramamurthy T.,
Chakraborty S., Nair G.B., Bhattacharya S.K.
Health impairments arising from drinking water
resources contaminated with Vibrio cholerae.
Schriftenr. Ver. Wasser Boden. Lufthyg. 2000;
105: 29-34
9. Chakraborty S.,
Mukhopadhyay A.K., Bhadra R.K., Ghosh A.N.,
Mitra R., Shimada T., Yamasaki S., Faruque S.M.,
Takeda Y., Colwell R.R., Nair G.B. Virulence
genes in the environmental strains of Vibrio
cholerae. Appl. Environ Microbiol. 2000 Sep;
66(9): 4022-4028
10. Garg P.,
Chakraborty S., Basu I., Datta S., Rajendran
K., Bhattacharya T., Yamasaki S., Bhattacharya
S.K., Takeda Y., Nair G.B., Ramamurthy T.
Expanding multiple antibiotic resistance among
clinical strains of Vibrio cholerae isolated
from 1992-1997 in Calcutta, India. Epidemiol.
Infect. 2000 Jun; 124(3): 393-399.
11. Chowdhury N.R.,
Chakraborty, S., Eampokalap, B., Chaicumpa
W., Chongsa-Nguan M., Moolasart P., Mitra R.,
Ramamurthy T., Bhattacharya S.K., Nishibuchi M.,
Takeda, Y., Nair, G.B. Clonal dissemination of
Vibrio parahaemolyticus displaying similar DNA
fingerprint but belonging to two different
serovars (O3:K6 and O4:K68) in Thailand and
India. Epidemiol. Infect. 2000 Aug; 125 (1):
17-25.
12. Chowdhury N.R.,
Chakraborty S., Ramamurthy T., Nishibuchi
M., Yamasaki S., Takeda Y., Nair G.B. Molecular
evidence of clonal Vibrio parahaemolyticus
pandemic strains. Emerg. Infect. Dis. 2000
Nov-Dec; 6 (6): 631-636.
13. Mukhopadhyay A.K.,
Chakraborty S., Takeda Y., Nair G.B., Berg
B.E. Characterization of VPI pathogenicity
island and CTXphi prophage in environmental
strains of Vibrio cholerae. J. Bacteriol. 2001
Aug; 183(16): 4737-4746.
14. Chakraborty S.,
Garg P., Ramamurthy R., Thungapathra M., Gautam
J.K., Kumar C., Maiti S., Yamasaki S., Shimada
T., Takeda Y., Ghosh A., Nair G.B. Comparison
of antibiogram, virulence genes, ribotypes and
DNA fingerprints of Vibrio cholerae of matching
serogroups isolated from hospitalized diarrhoea
cases and from the environment during 1997-1998
in Calcutta, India. J. Med. Microbiol. 2001 Oct;
50 (10): 879-888
15. Chhotray G.P., Pal
B.B., Khuntia H.K., Chowdhury N.R.,
Chakraborty S., Yamasaki S., Ramamurthy T.,
Takeda Y., Bhattacharya S.K., Nair G.B.
Incidence and molecular analysis of Vibrio
cholerae associated with cholera outbreak
subsequent to the super cyclone in Orissa,
India. Epidemiol Infect. 2002 Apr; 128 (2):
131-138
16. Chakraborty S.,
Senyuk V., Nucifora G. Genetic lesions and
perturbation of chromatin architecture: a road
to cell transformation. J. Cell Biochem. 2001;
82 (2): 310-325. Review
17. Chakraborty S.,
Senyuk V., Sitailo S., Chi Y., Nucifora G.
Interaction of EVI1 with c-AMP-responsive
element-binding protein-binding protein (CBP)
and p300/CBP-associated factor (P/CAF) results
in reversible acetylation of EVI1 and in
co-localization in nuclear speckles. J. Biol.
Chem. 2001 Nov 30; 276(48): 44936-44943.
18. Senyuk V.,
Chakraborty S., Mikhail F.M., Zhao R., Chi
Y., Nucifora G. The leukemia–associated
transcription repressor AML1/MDS1/EVI1 requires
CtBP to induce abnormal growth and
differentiation of murine hematopoietic cells.
Oncogene 2002 May 9; 21 (20): 3232-3240.
19. Chakraborty S.,
Sinha KK., Senyuk V., Nucifora G. SUV39H1
interacts with AML1 and abrogates AML1
transactivity. AML1 is methylated in vivo.
Oncogene 2003; 22: 5229-5237
20. Senyuk V., Sinha KK., Chakraborty S.,
Buonamici S., Nucifora G. P/CAF and GCN5
acetylate the AML1/MDS1/EVI1 fusion oncoprotein.
Biochem. Biophys. Res. Commun. 2003 Aug 8; 307
(4): 980-986
21. Buonamici S., Chakraborty S., Senyuk
V., Nucifora G. The role of EVI1 in normal and
leukemic cells. Blood Cells, Molecules, &
Diseases. 2003; 31(2):206-212
22. Chakraborty S., Buonamici S., Senyuk
V., Nucifora G. Ecotropic Viral
Integration 1 Site (EVI1) and Myelodysplastic
Syndrome 1 (MDS1)-EVI1. Atlas Genet Cytogenet
Oncol Haematol. May 2003.
URL:
http://www.infobiogen.fr/services/chromcancer/Genes/EVI103q26ID19.html
23. Chi Y., Senyuk V., Chakraborty S,
Wang X., Nucifora G. EVI1 promotes cell
proliferation by interacting with BRG1 and
blocking the repression of BRG1 on E2F activity.
J. Biol. Chem. 2003 Dec; 278(50): 49806-49811.
24. Laricchia-Robbio L, Fazzina
R, Li D, Rinaldi CR, Sinha KK, Chakraborty S,
Nucifora G. Point mutations in two Evi1
Zn fingers abolish EVI1-GATA1 interaction and
allow erythroid differentiation of murine bone
marrow cells. Mol. Cell Biol.
2006 Oct;26(20):7658-66.
25. Kuila N, Sahoo DP, Kumari M, Biswas S, Patnaik RS,
Pattnayak NC, Biswas G, Chakraborty S
EVI1, BAALC and AME: prevalence of the secondary mutations in chronic and
accelerated phases of chronic myeloid leukemia patients from eastern India.
Leuk Res. 2009 Apr;33(4):594-6.
26. Kuila N, Dash N, Sahoo DP, Pattnayak NC, Biswas G,
Chakraborty S. Presence of a new BCR-ABL kinase domain mutation, C330G in
an imatinib naive patient with chronic myeloid leukemia: very low prevalence of
BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia from
eastern India. Leuk Lymphoma. 2009 Apr;50(4):663-6.
27. Pradhan
AK, Kuila N, Singh S, Chakraborty S.
EVI1 up-regulates the stress
responsive gene SIRT1 which triggers deacetylation and degradation of EVI1.
Biochim Biophys Acta. 2011 Apr-Jun;1809(4-6):269-75.
28. Pradhan AK, Mohapatra
AD, Nayak KB, Chakraborty S. Acetylation of the
Proto-Oncogene EVI1 Abrogates Bcl-xL Promoter
Binding and Induces Apoptosis. PLOS ONE
(Accepted) 2011.
|